Evaluation of Carbohydrates Part 2

Abbott

Status: Completed

Conditions: Gastro-Intestinal Tolerance

Treatments: Other: CHO Experimental 4 Maltodextrin; Other: CHO Experimental 2 Digestion Resistant; Other: CHO Experimental 1 Slowly Digested; Other: CHO Control 1 and 2 Glucose; Other: CHO Experimental 3 Low Sugar

Study type: Interventional

Funder types: Industry

Identifiers

NCT03293706

BL37 Part 2

Details and patient eligibility

About

The study is single-blind with a randomized, cross-over design to evaluate gastrointestinal tolerance of carbohydrate blends.

Enrollment: 13 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Males or non-pregnant females in good health.
• Eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.

Exclusion criteria

• Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes, cardio-vascular disease or GI disease.
• Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

13 participants in 6 patient groups

CHO Control 1 Glucose

Active Comparator group

Description:

25 g glucose

Treatment:

Other: CHO Control 1 and 2 Glucose

CHO Control 2 Glucose

Active Comparator group

Description:

25 g glucose

Treatment:

Other: CHO Control 1 and 2 Glucose

CHO Experimental 1 Slowly Digested

Experimental group

Description:

25 g slowly-digested carbohydrate blend

Treatment:

Other: CHO Experimental 1 Slowly Digested

CHO Experimental 2 Digestion Resistant

Experimental group

Description:

25 g digestion-resistant carbohydrate blend

Treatment:

Other: CHO Experimental 2 Digestion Resistant

CHO Experimental 3 Low Sugar

Experimental group

Description:

25 g low sugar carbohydrate blend

Treatment:

Other: CHO Experimental 3 Low Sugar

CHO Experimental 4 Maltodextrin

Experimental group

Description:

25 g maltodextrin

Treatment:

Other: CHO Experimental 4 Maltodextrin